• Thymosin Alpha-1 TA1 10mg lyophilised research peptide vial – Dubai Peptides UAE
1 1

Omni Peptides

Thymosin Alpha-1 (TA1)

Dhs. 400.00 AED
Dhs. 400.00 AED
Sale Sold out
CHOOSE YOUR FORMAT

Size
Lyophilised & sealed vials
Independent COA · ≥99% purity
Cold-chain dispatch · same day Dubai
Discreet · unbranded outer packaging

Immune support, antiviral/immune resilience

Thymosin Alpha-1 (also known as Tα1 or Thymalfasin) is a synthetic version of the naturally occurring 28-amino acid peptide originally isolated from thymic tissue. This research compound has been extensively studied for its potent immunomodulatory properties and its role in enhancing host defense mechanisms. Preliminary and advanced preclinical investigations demonstrate that Thymosin Alpha-1 may stimulate T-cell maturation and differentiation, restore immune function in immunocompromised states, enhance antiviral and antitumor immunity, and exert direct cytoprotective effects. Researchers utilize this peptide in laboratory and animal models to explore mechanisms of immune reconstitution, infectious disease resistance, and cancer immunotherapy. As a research-grade compound, Thymosin Alpha-1 is intended exclusively for in vitro and animal studies. Scientists value its well-documented stability, low immunogenicity, and ability to provide insights into thymic peptide-mediated immune regulation.

Molecular Formula
C₁₂₉H₂₁₅N₃₃O₅₅
Molecular Weight
3108.3 g/mol
Sequence
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn

Research Applications

01 Immune System Modulation and Restoration
Preclinical studies show that Thymosin Alpha-1 significantly enhances T-cell function, increases IL-2 receptor expression, and promotes differentiation of immature thymocytes into mature, functional T-cells, particularly in models of thymic involution, chemotherapy-induced immunosuppression, and aging.
02 Antiviral and Antimicrobial Defense
Extensive research demonstrates potent activity against a broad range of viral pathogens (including hepatitis B/C, influenza, HIV, and SARS-CoV models) through upregulation of interferon-α/β production, NK cell activity, and CD8+ cytotoxic T-cell responses.
03 Cancer Immunotherapy Support
Thymosin Alpha-1 augments antitumor immunity by enhancing dendritic cell maturation, promoting Th1 cytokine profiles, and increasing tumor infiltration by effector lymphocytes in various preclinical tumor models, often in combination with checkpoint inhibitors or chemotherapeutic agents.
04 Vaccine Adjuvant Potential
Studies indicate that Thymosin Alpha-1 improves both humoral and cellular immune responses to vaccines, increasing antibody titers and memory T-cell formation in immunocompromised or elderly subjects.
05 Anti-Inflammatory and Tissue Protection
It modulates excessive inflammatory responses by balancing pro- and anti-inflammatory cytokine production, reducing sepsis mortality in animal models, and protecting against oxidative stress and organ damage in critical illness scenarios.

Storage & Handling

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.

Molecular Formula
C₁₂₉H₂₁₅N₃₃O₅₅
Molecular Weight
3108.3 g/mol
Sequence
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn

— About this compound

Thymosin Alpha-1 (TA1) is a synthetic immunomodulatory thymosin peptide.

Thymosin Alpha-1 (also known as Tα1 or Thymalfasin) is a synthetic version of the naturally occurring 28-amino acid peptide originally isolated from thymic tissue. This research compound has been extensively studied for its potent immunomodulatory properties and its role in enhancing host defense mechanisms. Preliminary and advanced preclinical investigations demonstrate that Thymosin Alpha-1 may stimulate T-cell maturation and differentiation, restore immune function in immunocompromised states, enhance antiviral and antitumor immunity, and exert direct cytoprotective effects. Researchers utilize this peptide in laboratory and animal models to explore mechanisms of immune reconstitution, infectious disease resistance, and cancer immunotherapy. As a research-grade compound, Thymosin Alpha-1 is intended exclusively for in vitro and animal studies. Scientists value its well-documented stability, low immunogenicity, and ability to provide insights into thymic peptide-mediated immune regulation.

VIAL ANATOMY
LYOPHILISED VIAL
Flip-off cap
Tamper-evident seal
Rubber stopper
Bacteriostatic-water compatible
Batch-labelled body
Lot & expiry printed
USP Type I glass
Borosilicate, sealed
Thymosin Alpha-1 (TA1) vial
Thymosin Alpha-1 (TA1)
10mg
DUBAI PEPTIDES
RESEARCH USE ONLY
BLACK RESEARCH SERIES

Research Applications

Where researchers apply it.

01 Immune System Modulation and Restoration
Preclinical studies show that Thymosin Alpha-1 significantly enhances T-cell function, increases IL-2 receptor expression, and promotes differentiation of immature thymocytes into mature, functional T-cells, particularly in models of thymic involution, chemotherapy-induced immunosuppression, and aging.
02 Antiviral and Antimicrobial Defense
Extensive research demonstrates potent activity against a broad range of viral pathogens (including hepatitis B/C, influenza, HIV, and SARS-CoV models) through upregulation of interferon-α/β production, NK cell activity, and CD8+ cytotoxic T-cell responses.
03 Cancer Immunotherapy Support
Thymosin Alpha-1 augments antitumor immunity by enhancing dendritic cell maturation, promoting Th1 cytokine profiles, and increasing tumor infiltration by effector lymphocytes in various preclinical tumor models, often in combination with checkpoint inhibitors or chemotherapeutic agents.
04 Vaccine Adjuvant Potential
Studies indicate that Thymosin Alpha-1 improves both humoral and cellular immune responses to vaccines, increasing antibody titers and memory T-cell formation in immunocompromised or elderly subjects.
05 Anti-Inflammatory and Tissue Protection
It modulates excessive inflammatory responses by balancing pro- and anti-inflammatory cytokine production, reducing sepsis mortality in animal models, and protecting against oxidative stress and organ damage in critical illness scenarios.

— Verified & Documented

Every vial is backed by a Certificate of Analysis.

Each lot is independently characterised by HPLC and mass spectrometry, with identity, mass and purity documented per batch and available on request.

Additional quality-control testing, including sterility, endotoxin and heavy metals, is conducted periodically across our product range.

>99%
HPLC Purity
MS
Identity Confirmed
Certificate of Analysis
THYMOSIN ALPHA-1 (TA1) · BATCH TA110-0114 · QC RELEASE
PASS
IdentityConfirmed
Mass12.66 mg
Purity99.45%
AppearanceWhite Lyophilised
LabJanoshik Analytical (Independant)
Date23/01/26

Storage & Handling

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.